Dr. Martens Plc (GB:DOCS)
LSE:DOCS
Want to see GB:DOCS full AI Analyst Report?
DOCS Stock Chart & Stats
69.90 p
-1.05 p(-1.49%)
At close: 4:00 PM EST
69.90 p
-1.05 p(-1.49%)
Day’s Range― - ―
52-Week Range53.05 p - 100.87 p
Previous CloseN/A
Volume189.83K
Average Volume (3M)1.82M
Market Cap
£621.91M
Enterprise Value943.62M
Total Cash (Recent Filing)£95.70M
Total Debt (Recent Filing)£397.10M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Nov 19, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend Yield3.36%
Share Statistics
EPS (TTM)0.02
Shares Outstanding967,928,340
10 Day Avg. Volume1,078,739
30 Day Avg. Volume1,820,978
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.34
Price to Sales (P/S)0.62
P/FCF Ratio2.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£97.50Price Target Upside39.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)0.05
Revenue Forecast (FY)£809.73M
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistent and rising free cash flow provides durable financial flexibility: it funds reinvestment in retail and e‑commerce, supports deleveraging and shareholder distributions, and creates a buffer against profit volatility, enabling multi‑quarter execution of strategic initiatives.
High Gross Profit MarginA near‑65% gross margin indicates lasting pricing power and favorable product economics rooted in brand strength and product mix. High product margins allow the company to absorb operating cost increases and invest in brand, retail and digital channels while preserving long‑term margin resilience.
Branded DTC Plus Wholesale ModelA dual DTC and wholesale model combines margin capture and brand control with broad market reach. DTC gives pricing, merchandising and consumer insights advantages, while wholesale scales volume—structural channel diversification that supports sustainable revenue mix optimization over multiple quarters.
Bears Say
Declining Revenue TrendA persistent revenue decline reduces operating leverage and constrains reinvestment. Over several quarters, shrinking top line forces tougher tradeoffs between marketing, retail footprint and margin protection, making multi‑period recovery and consistent margin improvement more difficult.
Very Thin Net Profit MarginA sub‑1% net margin leaves little room for adverse input costs, tariffs or promotional missteps. With such limited bottom‑line buffer, operational setbacks or macro headwinds can quickly erode earnings and cash generation, increasing the risk of volatile multi‑quarter outcomes.
Collapsed Return On Equity And Material LeverageA sharp ROE decline alongside notable leverage signals weakened capital efficiency: equity now generates very little return while debt remains meaningful. This limits strategic optionality, raises financing risk sensitivity, and constrains capital deployment for growth over coming quarters.
Dr. Martens Plc News
DOCS FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest share price was 53.05 p and its highest was 100.87 p in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is £621.91M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is Nov 19, 2026 which is in 183 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on May 19, 2026. The company reported 0.042 p earnings per share for the quarter, missing the consensus estimate of 0.044 p by -0.002 p.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Semiannually dividend of 0.85 p which represents an annual dividend yield of 3.36%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is <0.01.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 967,928,340 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of 0.042 p in its last earnings report, missing expectations of 0.044 p. Following the earnings report the stock price went up 3.266%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in GB:DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Martens Plc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£97.50 (39.48% Upside)
£97.50 (39.48% Upside)
Insider Transactions
Sold Shares
Worth £133.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.81%
12-Months-Change
Fundamentals
Return on Equity
4.40%
Trailing 12-Months
Asset Growth
-7.19%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
DOCS Stock 12 Month Forecast
Average Price Target
97.50 p
▲(39.48% Upside)
Technical Analysis
Options Prices
Currently, No data available
---